Rizzardi PH, de Farias Gabriel A, Martins ID, Carrard VC, Zanella VG, Girardi FM, et al. Metastatic melanoma of the major salivary glands - a systematic review. Med Oral Patol Oral Cir Bucal. 2025 Sep 1;30 (5):e736-44.
doi:10.4317/medoral.27216
https://dx.doi.org/doi:10.4317/medoral.27216
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49. |
PMid:33538338 |
2. Damsky WE, Theodosakis N, Bosenberg M. Melanoma metastasis: new concepts and evolving paradigms. Oncogene. 2014;33:2413-22. |
PMid:23728340 |
3. Helsing P, Robsahm TE, Vos L, Rizvi SM, Akslen LA, Veierød MB. Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location. J Am Acad Dermatol. 2016;75:975-82.e2. |
PMid:27546291 |
4. Hoersch B, Leiter U, Garbe C. Is head and neck melanoma a distinct entity?. A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol. 2006;155:771-7. |
PMid:16965427 |
5. Scott JF, Thompson CL, Vyas R, Honda K, Zender C, Rezaee R, et al. Parotid melanoma of unknown primary. J Cancer Res Clin Oncol. 2016;142:1529-37. |
PMid:27075178 |
6. Elshenawy Y, Youngberg G, Al-Abbadi MA. Unusual clinical presentation of cutaneous malignant melanoma metastatic to the parotid gland; initially discovered by fine needle aspiration: case report and review of literature. Diagn Cytopathol. 2011;39:373-6. |
PMid:20949472 |
7. Castellani G, Buccarelli M, Arasi MB, Rossi S, Pisanu ME, Bellenghi M, et al. BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. Cancers (Basel). 2023;15:4026. |
PMid:37627054 PMCid:PMC10452867 |
8. Clausen F, Poulsen H. Metastatic carcinoma of the jaws. Acta Pathol Microbiol Scand. 1963;57:361-74. |
PMid:14064805 |
9. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache. 2013;53:1541-7. |
PMid:24266334 |
10. Saravakos P, Kourtidis S, Hartwein J, Preyer S. Parotid Gland Tumors: A Multicenter Analysis of 1020 Cases. Increasing Incidence of Warthin's Tumor. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):2033-40. |
PMid:36452806 PMCid:PMC9702007 |
11. Bhatt AM, Mesa H, Chen S, Molden B, Hou T. FNA diagnosis of secondary malignancies in the parotid gland: over 20 years of experience from a single institute. J Am Soc Cytopathol. 2025;14:36-43. |
PMid:39322514 |
12. Bron LP, Traynor SJ, McNeil EB, O'Brien CJ. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113:1070-5. |
PMid:12782825 |
13. Gao N, Li LJ, Li Y, Wang L. Primary amelanotic malignant melanoma of the parotid gland: a case report. J Int Med Res. 2008;36:1435-39. |
PMid:19094455 |
14. Franzen A, Buchali A, Lieder A. The rising incidence of parotid metastases: our experience from four decades of parotid gland surgery. Acta Otorhinolaryngol Ital. 2017;37:264-9. |
PMid:28872155 PMCid:PMC5584096 |
15. Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010;74:134-48. |
PMid:19939701 |
16. Murali R, Thompson JF, Uren RF, Scolyer RA. Fine-needle biopsy of metastatic melanoma: clinical use and new applications. Lancet Oncol. 2010;11:391-400. |
PMid:20106719 |
17. Díaz KP, Gerhard R, Domingues RB, Martins LL, Prado Ribeiro AC, Lopes MA, et al. High diagnostic accuracy and reproducibility of fine-needle aspiration cytology for diagnosing salivary gland tumors: cytohistologic correlation in 182 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:226-35. |
PMid:24935698 |
18. Singh AD, Wani FA, Bhardwaj S. Diagnostic accuracy of FNAC and cyto-histopathological correlation in testicular and paratesticular mass lesions. Cytopathology. 2017;28:542-8. |
PMid:28913933 |
19. Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011;103:129-42. |
PMid:21081714 PMCid:PMC3022618 |
20. Liu ZF, Sylivris A, Wu J, Tan D, Hong S, Lin L, et al. Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis. Am J Clin Dermatol. 2024;25:513-25. |
PMid:38635019 |
21. Simonetti I, Trovato P, Granata V, Picone C, Fusco R, Setola SV, et al. Imaging Assessment of Interval Metastasis from Melanoma. J Pers Med. 2022 Jun 24;12:1033. |
PMid:35887530 PMCid:PMC9315548 |
22. Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol. 2017;112:136-52. |
PMid:28325255 |
23. López F, Rodrigo JP, Cardesa A, Triantafyllou A, Devaney KO, Mendenhall WM, et al. Update on primary head and neck mucosal melanoma. Head Neck. 2016;38:147-55. |
PMid:25242350 PMCid:PMC4986507 |
24. Gong HZ, Zheng HY, Li J. Amelanotic melanoma. Melanoma Res. 2019;29:221-30. |
PMid:30672881 |
25. Ordóñez NG. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update. Hum Pathol. 2014;45:191-205. |
PMid:23648379 |
26. Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008;35:433-44. |
PMid:18399807 |
27. Wertz AP, Durham AB, Malloy KM, Johnson TM, Bradford CR, McLean SA. Total versus superficial parotidectomy for stage III melanoma. Head Neck. 2017;39:1665-70. |
PMid:28481438 |
28. Domingues B, Lopes JM, Soares P, Pópulo H. Melanoma treatment in review. Immunotargets Ther. 2018;7:35-49. |
PMid:29922629 PMCid:PMC5995433 |
29. Alqathama A. BRAF in malignant melanoma progression and metastasis: potentials and challenges. Am J Cancer Res. 2020;10:1103-14. |
PMid:32368388 |
30. Kestel S, Uyar Göçün FP, Öğüt B, Erdem Ö. Metastatic melanoma: clinicopathologic features and overall survival comparison. Acta Dermatovenerol Alp Pannonica Adriat. 2022;31:93-100. |
PMid:36149038 |
31. Cherobin ACFP, Wainstein AJA, Colosimo EA, Goulart EMA, Bittencourt FV. Prognostic factors for metastasis in cutaneous melanoma. An Bras Dermatol. 2018;93:19-26. |
PMid:29641692 PMCid:PMC5871357 |
32. Ogata D, Namikawa K, Takahashi A, Yamazaki N. A review of the AJCC melanoma staging system in the TNM classification (eighth edition). Jpn J Clin Oncol. 2021;51:671-4. |
PMid:33709104 |
33. Bunnell AM, Nedrud SM, Fernandes RP. Classification and Staging of Melanoma in the Head and Neck. Oral Maxillofac Surg Clin North Am. 2022;34:221-34. |
PMid:35491079 |
34. Eddy K, Shah R, Chen S. Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities. Front Oncol. 2021;10:626129. |
PMid:33614507 PMCid:PMC7891057 |
35. Luan H, Jian L, He Y, Zhang T, Zhou L. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma. Sci Rep. 2022;12:13002. |
PMid:35906389 PMCid:PMC9338051 |
36. Mimica X, McGill M, Hay A, Karassawa Zanoni D, Shah JP, Wong RJ, et al. Distant metastasis of salivary gland cancer: Incidence, management, and outcomes. Cancer. 2020;126:2153-62. |
PMid:32097509 PMCid:PMC8224983 |
37. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. |
PMid:33782057 PMCid:PMC8005924 |